A Phase 3 interventional study of Experimental: Baofukang Suppository 7 days and Experimental: Baofukang Suppository 14 days in Vaginitis, sponsored by Peking University Shenzhen Hospital. Recruiting at 1 site in China. Open to female participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2025-06-12.
Sponsored by Peking University Shenzhen Hospital · Phase 3, Interventional, and Treatment
Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group.To evaluate the efficacy and safety after treatment.
Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group.
Group 1: Baofukang Suppository (1.74g), for vaginal use, 2 capsules per night for 7 days.
Group 2: Baofukang Suppository (1.74g), for vaginal use, 2 capsules per night for 14 days.
The efficacy and safety will be evaluated 7\~14 days after treatment and 35\~42 days after treatment.
98 studies on the registry are indexed under Vaginitis; 12 are open to participants now.
This study's planned enrollment of 50 is below the median of 108 across 71 interventional studies indexed under Vaginitis.
Browse Vaginitis studies →Peking University Shenzhen Hospital is the lead sponsor of 17 studies on the registry; 12 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Aerobic vaginitis diagnosed based on present ：
Exclusion Criteria:
Baofukang Suppository (1.74g), for vaginal external use, 2 capsules per night for 7 days
Drug: Experimental: Baofukang Suppository 7 days
Baofukang Suppository (1.74g), for vaginal external use, 2 capsules per night for 14days
Drug: Experimental: Baofukang Suppository 14 days
Experimental: Baofukang Suppository 7 days
Also known as: Baofukang Suppository 7 days
Experimental: Baofukang Suppository 14 days
Also known as: Baofukang Suppository 14 days
Cure rate
A vaginal smear composite Donders score of 1 to 2 represents normality. A score of more than 2 is aerobic vaginitis. There are four variables(Lactobacillary; leucocytes; toxic leukocytes; parabasal cells; background flora). Detail see references Links.
Time frame: First week after treatment
Cure rate
A vaginal smear composite Donders score of 1 to 2 represents normality. A score of more than 2 is aerobic vaginitis. There are four variables(Lactobacillary; leucocytes; toxic leukocytes; parabasal cells; background flora).Detail see folowing references.
Time frame: First month after the treatment
Side affect
Number of Participants Experiencing AEs Following the First Dose of the Study Product
Time frame: First week after treatment
Plan to share: No
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peking University Shenzhen Hospital